Richard D. Truesdell, Jr.

Davis Polk advised CureVac N.V. on its $245.3 million initial public offering of 15,333,332 of its common shares, which includes 1,999,999 common shares from the full exercise of the…

Davis Polk advised the representatives of the several underwriters in connection with the $204 million follow-on offering of 2,415,000 shares of common stock of Overstock.com, Inc.,…

Davis Polk advised the representative of the several underwriters in connection with the SEC-registered offering of 30,675,000 shares of common stock of Plug Power Inc. for approximately …

Davis Polk advised Automatic Data Processing, Inc. (“ADP”) in connection with its SEC-registered offering of $1 billion aggregate principal amount of 1.250% senior notes due 2030.  …

Davis Polk advised Freeline Therapeutics Holdings plc on its $158.8 million initial public offering of 8,823,529 American depositary shares representing 8,823,529 ordinary shares, which…

Davis Polk advised the sole book-running manager and representative of the underwriters in connection with the $59 million follow-on offering of 310,500 shares of common stock of Kinsale…

Davis Polk advised Freeport-McMoRan Inc. (“FCX”) in connection with its SEC-registered offering of $1.5 billion of senior notes. The offering consisted of $650 million of 4.375% senior…

Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $160 million initial public offering of 10,714,286 shares of common…

Davis Polk advised BRP Group, Inc. on its $175.2 million follow-on offering of 13,225,000 shares of Class A common stock, which includes 1,725,000 shares from the full exercise of the…

Davis Polk advised the sole book-running manager in connection with the $215.6 million common stock offering of 6,900,000 shares of common stock of Editas Medicine, Inc. The common…